Last reviewed · How we verify
pd-1 and dc-cik cells
pd-1 and dc-cik cells is a Small molecule drug developed by Allife Medical Science and Technology Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | pd-1 and dc-cik cells |
|---|---|
| Sponsor | Allife Medical Science and Technology Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma (PHASE1, PHASE2)
- Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors (PHASE1, PHASE2)
- Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC (PHASE1, PHASE2)
- A Study of PD1 Combined With Dc-cik in the Treatment of Solid Tumors (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pd-1 and dc-cik cells CI brief — competitive landscape report
- pd-1 and dc-cik cells updates RSS · CI watch RSS
- Allife Medical Science and Technology Co., Ltd. portfolio CI
Frequently asked questions about pd-1 and dc-cik cells
What is pd-1 and dc-cik cells?
pd-1 and dc-cik cells is a Small molecule drug developed by Allife Medical Science and Technology Co., Ltd..
Who makes pd-1 and dc-cik cells?
pd-1 and dc-cik cells is developed by Allife Medical Science and Technology Co., Ltd. (see full Allife Medical Science and Technology Co., Ltd. pipeline at /company/allife-medical-science-and-technology-co-ltd).
What development phase is pd-1 and dc-cik cells in?
pd-1 and dc-cik cells is in Phase 1.